The Vigabatrin REMS Program is needed by the FDA to guarantee notified risk-benefit choices before launching treatment, and to make certain appropriate use of vigabatrin while individuals are treated. It is not feasible for your healthcare provider to recognize when vision loss will occur.
The most typical adverse effects of SABRIL in kids 3 to 16 years is weight gain. With extreme vision loss, you may just be able to see things directly before you (occasionally called one-track mind"). You go to danger for vision loss with any amount of SABRIL.
If you are expecting or plan to get pregnant, inform your healthcare provider. If vision testing can not be done, your healthcare provider might proceed suggesting SABRIL, yet will not be able to expect any kind of vision loss. If vision examinations are refrained from doing routinely, your doctor might quit prescribing SABRIL for you (or your child).